stella
beta
A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer. — Stella
Recruiting
Back to Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer trials
Trial locations
(13 sites)
South Korea
KR82010, Goyang-si, Gyeonggi-do
KR82008, Suwon, Gyeonggi-do
KR82009, Suwon, Gyeonggi-do
KR82006, Yangsan, Gyeongsangnam-do
KR82012, Hwasun Gun, Jeollanam-do
KR82001, Seoul
KR82002, Seoul
KR82003, Seoul
KR82004, Seoul
KR82005, Seoul
KR82007, Seoul
KR82011, Seoul
KR82013, Seoul
View full record on ClinicalTrials.gov